Navigation Links
Scientist Confident of Combating Allergy in Five Years
Post Your Comments:
Breaking Medicine Technology:Maxygen, Inc. Announces Extension of Dutch Auction Tender Offer 2Boston Scientific Announces Pricing of $2 Billion of Senior Notes 2Boston Scientific Announces Pricing of $2 Billion of Senior Notes 3Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 2Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 3Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 4Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 5Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 6Chicken Pox Vaccine May Also Reduce Risk of Shingles Among Children 62585 1Chicken Pox Vaccine May Also Reduce Risk of Shingles Among Children 62585 2Chicken Pox Vaccine May Also Reduce Risk of Shingles Among Children 62585 3Senate Approval of Mikulski Amendment Further Opens Health Care Bill to Massive Federal Funding of Abortion 62581 1Senate Approval of Mikulski Amendment Further Opens Health Care Bill to Massive Federal Funding of Abortion 62581 2Ginger Prices Could Skyrocket on H1N1 Fears 62576 1Ginger Prices Could Skyrocket on H1N1 Fears 62576 2